Author:
Waldrop Greer,Zhong Jixin,Peters Matthew,Goud Aditya,Chen Yin-Hsiu,Davis Stephen N.,Mukherjee Bhramar,Rajagopalan Sanjay
Funder
NIH
Mid-Atlantic Nutrition Obesity Research Center
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference87 articles.
1. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin;Ahrén;Diabetes Care,2014
2. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: A randomized, double-blind, non-inferiority trial;Arechavaleta;Diabetes, Obesity & Metabolism,2011
3. Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes;Aschner;Diabetes, Obesity & Metabolism,2010
4. AstraZeneca; Bristol-Myers Squibb 18-week add-on to metformin comparison of saxagliptin and sitagliptin in adult patients with type 2 diabetes (T2D). Clin [Internet]National Libr Med NCT00666458.
5. GLP-1 and energy balance: An integrated model of short-term and long-term control;Barrera;Nature Reviews. Endocrinology,2011
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献